Paradigm Biopharmaceuticals Ltd.ASX: PAR

Deferral of AGM and Financial Reporting Obligations

· Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Paradigm Biopharmaceuticals Ltd. has announced the deferral of its Annual General Meeting and financial reporting obligations due to its appointment of administrators. The AGM, originally required to be held by the end of November, will not take place by that date. The company must hold the AGM within two months after the end of the deferral period and present all outstanding financial reports at that time.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/deferral-of-agm-and-financial-reporting-obligations

Release

ASX RELEASE 23 October 2026 Deferral of AGM and Financial Reporting Obligations Deferral of Obligations Paradigm Biopharmaceuticals Limited (Administrators Appointed) (ASX: PAR) (Company) refers to the appointment of Christopher Pattinson and Hayden White of FTI Consulting as Joint and Several...

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Later from Paradigm Biopharmaceuticals

All Paradigm Biopharmaceuticals news releases